Skip to content

FT819 in B-cell Mediated Autoimmune Diseases

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517397-25-00
Acronym
FT819-102
Enrollment
50
Registered
2025-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B-cell Mediated Autoimmune Diseases

Interventions

None listed

Sponsors

Fate Therapeutics Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026